PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-47354 | Pharmaceuticals and Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Painful drugs for hip osteoarthritis Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET
7.1 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA PAINFUL DRUGS FOR HIP OSTEOARTHRITIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Pfizer
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Bayer
16.3 Daiichi Sankyo
16.4 Tide Pharmaceutical
16.5 Sanofi
16.6 GlaxoSmithKline
16.7 Johnson and Johnson
16.8 Horizon Pharma
16.9 Eli Lilly
16.10 Novartis
16.11 Abiogen Pharma
16.12 Mylan
16.13 Abbott
16.14 TEVA
16.15 Astellas Pharma
16.16 Almatica Pharma
16.17 Iroko Pharmaceuticals
16.18 Hengrui Pharmaceutical
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredInjection type
Exterior
Oral type
Major Downstream Industry Covered
Personal care
medical care
Companies
Pfizer
Bayer
Daiichi Sankyo
Tide Pharmaceutical
Sanofi
GlaxoSmithKline
Johnson and Johnson
Horizon Pharma
Eli Lilly
Novartis
Abiogen Pharma
Mylan
Abbott
TEVA
Astellas Pharma
Almatica Pharma
Iroko Pharmaceuticals
Hengrui Pharmaceutical
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.